Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy

NCT01501370 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Vorinostat
DRUG: Lenalidomide
DRUG: Dexamethasone
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Tiziana Marangon